Paper37315641
Natural product-derived therapies for treating drug-resistant epilepsies: From ethnopharmacology to evidence-based medicine.
Challal S and 6 others. J Ethnopharmacol, 2023. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. Natural product-derived therapies for treating drug-resistant epilepsies: From ethnopharmacology to evidence-based medicine. Papers, record 37315641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37315641
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Natural product-derived therapies for treating drug-resistant epilepsies: From ethnopharmacology to evidence-based medicine.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biological Products | Major topic |
| Epilepsy | Major topic |
| Cannabidiol | Major topic |
| Drug Resistant Epilepsy | Major topic |
| Plants, Medicinal | Major topic |
| Animals | |
| Humans | |
| Ethnopharmacology | |
| Anticonvulsants | |
| Plant Extracts | |
| Evidence-Based Medicine | |
| Alkaloids | |
| Sesquiterpenes |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42944146 | Beyond Seizure Suppression: Caffeic Acid Phenethyl Ester and 10-Hydroxy-2-Decenoic Acid Improve Anxiety-like and Cognitive Behaviors in PTZ-Challenged Zebrafish. | Vet Sci | 2026 | https://conductscience.org/library/papers/42944146 | PubMed |
| 42828421 | Apoptin-Derived Peptide Alleviates Temporal Lobe Epilepsy (TLE) by Limiting Neuronal Ca2+ Overload Through the HSPA1A-AP2B1 Axis. | CNS Neurosci Ther | 2026 | https://conductscience.org/library/papers/42828421 | PubMed |
| 42656877 | Effects of herbal medicines and their phytoconstituents on vagus nerve stimulation: a systematic review of in vivo studies. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42656877 | PubMed |
| 42450128 | Neuroinflammation in Epilepsy: Biochemical and Molecular Mechanisms and Implications for Natural Product-Driven Drug Discovery. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42450128 | PubMed |
| 42303582 | Lipid-based Nano-delivery systems as a promising strategy for the treatment of epilepsy: Current status and challenges. | Epilepsia Open | 2026 | https://conductscience.org/library/papers/42303582 | PubMed |
| 41735175 | Exploring Linalool-Based Phytotherapy for Excitatory/Inhibitory Imbalance in Alzheimer's Disease: A Review of Lavender and Cannabis Therapeutic Effects on Sleep, Seizures, and Cognition. | Phytother Res | 2026 | https://conductscience.org/library/papers/41735175 | PubMed |
| 40621710 | L-quebrachitol Modulates the Anti-convulsant Effects of Carbamazepine Possibly Through Voltage-gated Sodium Channel Blocking Mechanism in Chicks: In Vivo and In Silico Studies. | Brain Behav | 2025 | https://conductscience.org/library/papers/40621710 | PubMed |
| 40427547 | The Anticonvulsant Effects of Different Cannabis Extracts in a Zebrafish Model of Epilepsy. | Biomolecules | 2025 | https://conductscience.org/library/papers/40427547 | PubMed |
| 40332554 | Herbal nanoparticles: bridging traditional medicine and modern science in epilepsy treatment. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/40332554 | PubMed |
| 40006000 | GABAA Receptors Are Involved in the Seizure Blockage Prompted by a Polyphenol-Rich Extract of White Grape Juice in Rodents. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40006000 | PubMed |
| 39279709 | A Revolutionary Approach for Combating Efflux Transporter-mediated Resistant Epilepsy: Advanced Drug Delivery Systems. | Curr Pharm Des | 2025 | https://conductscience.org/library/papers/39279709 | PubMed |
| 38962319 | Harnessing the power of natural alkaloids: the emergent role in epilepsy therapy. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38962319 | PubMed |
| 38653825 | Analysis of the action mechanisms and targets of herbal anticonvulsants highlights opportunities for therapeutic engagement with refractory epilepsy. | J Mol Med (Berl) | 2024 | https://conductscience.org/library/papers/38653825 | PubMed |
| 38270158 | Inhibition of Seizure-Like Paroxysms and Toxicity Effects of Securidaca longepedunculata Extracts and Constituents in Zebrafish Danio rerio. | ACS Chem Neurosci | 2024 | https://conductscience.org/library/papers/38270158 | PubMed |
| 38116109 | Alterations in brain network functional connectivity and topological properties in DRE patients. | Front Neurol | 2023 | https://conductscience.org/library/papers/38116109 | PubMed |
| 38015370 | Imperatorin interacts additively with novel antiseizure medications in the mouse maximal electroshock-induced seizure model: an isobolographic transformation. | Pharmacol Rep | 2024 | https://conductscience.org/library/papers/38015370 | PubMed |
| 37821793 | Anticonvulsant effects of isopimpinellin and its interactions with classic antiseizure medications and borneol in the mouse tonic-clonic seizure model: an isobolographic transformation. | Pharmacol Rep | 2023 | https://conductscience.org/library/papers/37821793 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37315641
GET https://conductscience.org/api/papers/v1/37315641/authors